bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Select Page

Sputum analysis by flow cytometry; an effective platform to analyze the lung environment

by Dale Harrison | Aug 17, 2022 | Publications

“Sputum analysis by flow cytometry; an effective platform to analyze the lung environment” PLoS ONE – August 17, 2022   Authors Bederka L.H., Sanchez JR, Rebeles J, Araujo PR, Grayson MH, Lai S-C, et al.   Abstract Low-dose computed tomography...

bioAffinity Technologies Presents Scientific Discoveries for Porphyrin Applications in Flow Cytometry

by Dale Harrison | Jul 19, 2022 | Events

July 21, 2022 bioAffinity Technologies Presents Scientific Discoveries for Porphyrin Applications in Flow Cytometry Senior Vice President William Bauta, Ph.D., will present research leading to development of a product for use with flow cytometry, including its use...

bioAffinity Technologies Presents CyPath® Lung advancements at the Cleveland Clinic Symposium Advancing Early Lung Cancer Detection

by Dale Harrison | Apr 25, 2022 | Events

April 28, 2022 bioAffinity Technologies Presents CyPath® Lung advancements at the Cleveland Clinic Symposium Advancing Early Lung Cancer Detection Chief Medical and Science Officer and Executive Vice President Vivienne Rebel, MD, PhD, will present at the Cleveland...

Maria Zannes, President & CEO, will present at BioMed’s BioFest Invest on March 30, 2022

by Maria Zannes | Mar 24, 2022 | Events

Maria Zannes, President & CEO, will discuss keys to a start-up company’s success as part of San Antonio BioMed’s BioFest Invest event on March 30, 2022.  Zannes will be on a panel of CEOs presenting to investors, companies and business leaders at the annual spring...
Next Entries »

Categories

  • Articles (28)
  • Events (38)
  • News (53)
  • Press Releases (138)
  • Publications (17)

Recent Posts

  • Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules September 9, 2025
  • U.S. Medicine Magazine Spotlights CyPath® Lung as Promising Tool to Improve Lung Cancer Detection in Veterans, Lower Costs to the VA September 3, 2025
  • New Test Shows Promise for Improving Lung Cancer Detection, Reducing Costs for VA – US Medicine, the Voice of Federal Medicine August 29, 2025
  • bioAffinity Technologies Appoints New Members to Board of Directors August 18, 2025
  • bioAffinity Technologies Announces Closing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds August 14, 2025
CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Copyright © 2023 bioAffinity Technologies, Inc.